LEMSIP first signs nasal spray 20ml
Images for illustrative purposes only
Lemsip First Action is a nasal treatment that combats colds immediately and decreases their duration. Using it at the onset of a cold will help you recover up to two days quicker, ensuring you can get back to daily life with minimal disruption. Containing powerful ingredients, including Carragelose and Kappa Carrageenan, Lemsip First Action Nasal treatment helps trap cold viruses and curb the symptoms.
- Relieves the symptoms of colds
- Speeds up the healing time by up to two days
- Easy to use
* Select options above to enable
LEMSIP first signs nasal spray 20ml
Looking for Next Day delivery?
Order before 15:30 for next day delivery on working days
Lemsip First Action contains carragelose and kappa carrageenan to treat cold symptoms and ensure they don't develop. By creating a shielding layer on the nasal mucosa, the medication prevents cold viruses from spreading, giving users a quicker recovery time.
This medicine can cause side effects. Prolonged spray can cause nasal irritation, so stop usage if you notice any pain. The ingredients can cause allergic reactions, so please read the leaflet before using the spray. If you develop flu-like symptoms or notice you aren't not getting any better, speak to your GP or another healthcare professional.
Who can use Lemsip First Action nasal spray?
Lemsip First Action Nasal Spray (20ml) is suitable for anyone over one year old. You can also use it during pregnancy, making the spray one of the best treatments available.
How should I use the spray?
Close one nostril and spray the medicine into the other nostril a few times daily. Use the spray head carefully and ensure it doesn't go too far into your nose. It's also essential to clean the nozzle after each use to prevent the spread of bacteria.
How does Lemsip First Action work?
Colds are common in the UK. A full-blown cold will infect healthy cells and last a couple of weeks. By using Lemsip's spray, you can halt the speed at which cold symptoms develop and have an early recovery.
No additional information available.
